United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

nucare plc - glucose monohydrate; citric acid anhydrous; potassium chloride; sodium citrate dihydrate; sodium chloride - granules for oral solution - 3.58gram ; 128mg ; 300mg ; 390mg ; 470mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

e m pharma - glucose monohydrate; citric acid anhydrous; potassium chloride; sodium citrate dihydrate; sodium chloride - granules for oral solution - 3.58gram ; 128mg ; 300mg ; 390mg ; 470mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - sodium citrate - granules for oral solution - 4gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lloyds pharmacy ltd - sodium chloride; sodium citrate dihydrate; potassium chloride; citric acid anhydrous; glucose monohydrate - granules for oral solution - 470mg ; 390mg ; 300mg ; 128mg ; 3.58gram

Israel - English - Ministry of Health

cts chemical industries ltd, israel - glucose monohydrate; potassium chloride; sodium chloride; sodium citrate - solution (oral) - glucose monohydrate 14.85 mg / 1 ml; sodium citrate 2.20 mg / 1 ml; potassium chloride 1.50 mg / 1 ml; sodium chloride 2.70 mg / 1 ml - combinations of electrolytes - for the prevention of dehydration by replacing fluids and electrolytes loss associated with conditions such as acute diarrhoea.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dynapharm marketing (m) sdn bhd - sodium citrate; diphenhydramine hydrochloride; ammonium chloride -

Ireland - English - HPRA (Health Products Regulatory Authority)

npbi b.v. - sodium citrate citric acid glucose sodium acid phosphate -

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - dexamethasone sodium metasulfobenzoate 0.076%{relative} equivalent to 0.05% w/v dexamethasone; framycetin sulfate 0.67%{relative} equivalent to 0.5% framycetin;  ; gramicidin 0.005%{relative} - ear/eye drops - active: dexamethasone sodium metasulfobenzoate 0.076%{relative} equivalent to 0.05% w/v dexamethasone framycetin sulfate 0.67%{relative} equivalent to 0.5% framycetin   gramicidin 0.005%{relative} excipient: citric acid monohydrate hydrochloric acid lithium chloride as lithium chloride solution 50%w/v methylated spirits phenethyl alcohol polysorbate 80 purified water sodium citrate dihydrate sodium hydroxide - in the eye: for the short term treatment of steroid responsive conditions of the eye when prophylactic antibiotic treatment is also required, after excluding the presence of fungal or viral disease. in the ear: otitis externa.

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - potassium citrate; sodium chloride; d-glucose, anhydrous; glycine; citric acid monohydrate - potassium citrate 0.75 g/litre; sodium chloride 53.44 g/litre; d-glucose, anhydrous 278.75 g/litre; glycine 38.56 g/litre; citric acid monohydrate 3.28 g/litre - oral nutrient/electrolyte

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - tazobactam sodium, quantity: 537 mg (equivalent: tazobactam, qty 500 mg); ceftolozane sulfate, quantity: 1147 mg (equivalent: ceftolozane, qty 1000 mg) - injection, powder for - excipient ingredients: arginine; sodium chloride; citric acid - zerbaxa (ceftolozane/tazobactam) is indicated for the treatment of the following infections in adults suspected or proven to be caused by designated susceptible microorganisms: - complicated intra-abdominal infections in combination with metronidazole - complicated urinary tract infections, including pyelonephritis - nosocomial pneumonia, including ventilator-associated pneumonia (vap),consideration should be given to published therapeutic guidelines on the appropriate use of antibacterial agents.